Publications scientifiques Bordet

Publications scientifiques Bordet

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.
Auteurs Delbart W, Karfis I, Vercruyssen M, De Wind R, Meuleman N, Wimana Z, Flamen P, Woff E
Auteurs (entité) FLAMEN PATRICK
Revue Eur J Nucl Med Mol Imaging
Date de publication 2025-08

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.
Auteurs Delbart W, Karfis I, Vercruyssen M, De Wind R, Meuleman N, Wimana Z, Flamen P, Woff E
Auteurs (entité) WOFF ERWIN
Revue Eur J Nucl Med Mol Imaging
Date de publication 2025-08

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.
Auteurs Arecco L, Gentile G, Gerosa R, Lambertini M, Buisseret L, De Caluwé A, de Azambuja E
Auteurs (entité) DE AZAMBUJA EVANDRO
Revue Curr Opin Oncol
Date de publication 2025-08

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.
Auteurs Arecco L, Gentile G, Gerosa R, Lambertini M, Buisseret L, De Caluwé A, de Azambuja E
Auteurs (entité) BUISSERET LAURENCE
Revue Curr Opin Oncol
Date de publication 2025-08

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.
Auteurs Arecco L, Gentile G, Gerosa R, Lambertini M, Buisseret L, De Caluwé A, de Azambuja E
Auteurs (entité) DE CALUWE ALEX
Revue Curr Opin Oncol
Date de publication 2025-08

Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.
Auteurs Joaquin Garcia A, Semba T, Rediti M, McGrail DJ, Xie X, Wang X, Rampa DR, Venet D, Buisseret L, Majjaj S, Kammler R, Colleoni M, Loi S, Viale G, Regan MM, Rothé F, Sotiriou C, Ueno NT
Auteurs (entité) BUISSERET LAURENCE
Revue iScience
Date de publication 2025-08

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.
Auteurs Joaquin Garcia A, Semba T, Rediti M, McGrail DJ, Xie X, Wang X, Rampa DR, Venet D, Buisseret L, Majjaj S, Kammler R, Colleoni M, Loi S, Viale G, Regan MM, Rothé F, Sotiriou C, Ueno NT
Auteurs (entité) SOTIRIOU CHRISTOS
Revue iScience
Date de publication 2025-08

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.
Auteurs Joaquin Garcia A, Semba T, Rediti M, McGrail DJ, Xie X, Wang X, Rampa DR, Venet D, Buisseret L, Majjaj S, Kammler R, Colleoni M, Loi S, Viale G, Regan MM, Rothé F, Sotiriou C, Ueno NT
Auteurs (entité) MAJJAJ SAMIRA
Revue iScience
Date de publication 2025-08

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00.

Iron-deficiency anemia evaluation and treatment in hospitalized cancer patients: a feasibility study.
Auteurs Meyers M, Paesmans M, Fleur W, Libert I, Klášterský J
Auteurs (entité) KLASTERSKY JEAN
Revue Support Care Cancer
Date de publication 2025-08

Iron-deficiency anemia evaluation and treatment in hospitalized cancer patients: a feasibility study.

Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasmus

Publications scientifiques d'Erasmus

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Publications scientifiques de l'Hôpital pour enfants Reine Fabiola

Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Publications scientifiques de Jules Bordet